Pancreatic adenocarcinoma

Autor: Jp, Arnoletti, Behrman S, Ben-Josef E, Ab, Benson Rd, Jd, Berlin, Jl, Cameron, Es, Casper, Sj, Cohen, Duff M, Jd, Ellenhorn, Wg, Hawkins, Jp, Hoffman, Bw, Kuvshinoff Nd, Mp, Malafa, Peter Muscarella, Ek, Nakakura, Ar, Sasson, Ma, Tempero, Sp, Thayer, Ds, Tyler, Rs, Warren, Whiting S, Willett C, Ra, Wolff

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7835918e083aa15e9e6e032b239e8797
http://europepmc.org/abstract/med/20876541

Correction: Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma.

Autor: Kim DW; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Beato F; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Kim Y; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL 33612, USA., Tassielli AF; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Dai R; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Denbo JW; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Hodul PJ; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Malafa MP; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Fleming JB; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

Publikováno v: Oncotarget [Oncotarget] 2024 Jul 02; Vol. 15, pp. 441. Date of Electronic Publication: 2024 Jul 02.

Editorial Expression of Concern: Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.

Autor: Li Y; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lauriola M; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Kim D; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Francesconi M; EMBL-CRG Systems Biology Unit, Centre for Genomic Regulation (CRG), Dr. Aiguader, Barcelona, Spain., D'Uva G; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Shibata D; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Malafa MP; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yeatman TJ; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Gibbs Cancer Center and Research Institute, Spartanburg, SC, USA., Coppola D; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. domenico.coppola@moffitt.org., Solmi R; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy. rossella.solmi@unibo.it., Cheng JQ; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. jin.cheng@moffitt.org.

Publikováno v: Oncogene [Oncogene] 2024 Mar; Vol. 43 (11), pp. 837.

p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.

Autor: Nasir A; Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; Division of Neuroendocrine Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; Genentech-Roche Tissue Diagnostics, Personalized Health Care Solutions, Tucson, AZ, U.S.A.; BJ's Diagnostic & Precision Oncology, Tampa, FL, U.S.A., Ahmed MK; BJ's Diagnostic & Precision Oncology, Tampa, FL, U.S.A., Saller JJ; Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A., Henderson-Jackson EB; Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A., Malafa MP; Department of Gastrointestinal Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A., Yeatman TJ; Department of Gastrointestinal Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; Department of Gastrointestinal Oncology and Surgery, Tampa General Hospital Cancer Center, Tampa, FL, U.S.A., Coppola D; Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; domenico.coppola@fdhs.com.; Division of Neuroendocrine Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.; Florida Digestive Health Specialists, Bradenton, FL, U.S.A.

Publikováno v: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2023 Nov-Dec; Vol. 20 (6), pp. 522-530.

Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

Autor: Chiorean EG; Fred Hutchinson Cancer Center., Chiaro MD; University of Colorado Cancer Center., Tempero MA; UCSF Helen Diller Family Comprehensive Cancer Center., Malafa MP; Moffitt Cancer Center., Benson AB; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Cardin DB; Vanderbilt-Ingram Cancer Center., Christensen JA; University of Michigan Rogel Cancer Center., Chung V; City of Hope National Medical Center., Czito B; Duke Cancer Institute., Dillhoff M; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Donahue TR; UCLA Jonsson Comprehensive Cancer Center., Dotan E; Fox Chase Cancer Center., Fountzilas C; Roswell Park Comprehensive Cancer Center., Glazer ES; The University of Tennessee Health Science Center., Hardacre J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Hawkins WG; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Klute K; Fred & Pamela Buffett Cancer Center., Ko AH; UCSF Helen Diller Family Comprehensive Cancer Center., Kunstman JW; Yale Cancer Center/Smilow Cancer Hospital., LoConte N; University of Wisconsin Carbone Cancer Center., Lowy AM; UC San Diego Moores Cancer Center., Masood A; Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Moravek C; Pancreatic Cancer Action Network., Nakakura EK; UCSF Helen Diller Family Comprehensive Cancer Center., Narang AK; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Nardo L; UC Davis Comprehensive Cancer Center., Obando J; Duke Cancer Institute., Polanco PM; UT Southwestern Simmons Comprehensive Cancer Center., Reddy S; O'Neal Comprehensive Cancer Center at UAB., Reyngold M; Memorial Sloan Kettering Cancer Center., Scaife C; Huntsman Cancer Institute at the University of Utah., Shen J; Stanford Cancer Institute., Truty MJ; Mayo Clinic Comprehensive Cancer Center., Vollmer C; Abramson Cancer Center at the University of Pennsylvania., Wolff RA; The University of Texas MD Anderson Cancer Center., Wolpin BM; Dana-Farber/Brigham and Women's Cancer Center., Rn BM; National Comprehensive Cancer Network., Lubin S; National Comprehensive Cancer Network., Darlow SD; National Comprehensive Cancer Network.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Jul; Vol. 21 (7), pp. 753-782.